Moreover, a recent genomic landscape of 10,000 metastatic tumor revealed that TSC2 missense mutations were presented in 294 patients with different types of cancer, but only one mutation was identified in 93 patients with PTC-related metastasis (11). Here, TSC2 is linked to metastatic neoplasm.